Novynette (Desogestrel, Ethinylestradiol)

Desogestrel/Ethinylestradiol, the active ingredient in Novynette, is a combined oral contraceptive presented as an oral tablet for oral use. It works by inhibiting ovulation, altering cervical mucus, and changing the endometrial lining to prevent pregnancy in women of reproductive age.

GNH USA supplies Novynette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU regulatory standards and is distributed under strict quality controls.

Novynette, a combined oral contraceptive, is indicated for hormonal contraception. - Prevention of pregnancy: Provides reliable contraceptive protection when taken as directed. - Menstrual cycle control: Helps achieve more predictable menstrual bleeding. - Management of dysmenorrhea: May reduce menstrual pain associated with hormonal cycles.

Novynette may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Nausea: Mild to moderate stomach upset. - Breast tenderness: Sensitivity or swelling of breast tissue. - Headache: Transient cranial discomfort. - Spotting: Irregular light bleeding between periods. - Weight gain: Slight increase in body weight. - Mood changes: Fluctuations in emotional state.

Serious or Rare Side Effects: - Deep vein thrombosis: Formation of blood clots in deep veins. - Pulmonary embolism: Blockage of pulmonary arteries by clots. - Stroke: Interruption of blood flow to the brain. - Myocardial infarction: Heart attack due to coronary blockage. - Severe allergic reaction: Anaphylaxis or angioedema. - Liver tumor: Rare hepatic neoplasm.

Novynette requires careful consideration of several safety aspects before use. - Contraindicated in pregnancy: Category X, do not use during pregnancy. - Smoking over age 35: Increased risk of cardiovascular events; avoid use. - History of thromboembolic disorders: Assess risk before prescribing. - Liver disease: Use with caution in hepatic impairment. - Interactions with enzyme inducers: May reduce contraceptive efficacy. - Store at ambient temperature: Keep in the original pack, protect from moisture and heat.

Novynette can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin): May markedly reduce hormone levels. - Antiepileptic drugs (e.g., carbamazepine): Can lower contraceptive effectiveness. - Protease inhibitors: May increase risk of adverse hormonal effects.

Moderate Interactions (Monitor Closely): - Antifungals (e.g., ketoconazole): May raise estrogen concentrations. - SSRIs (e.g., sertraline): Potentially increase bleeding tendency. - St. John’s wort: May diminish contraceptive reliability.